The inquiry is the latest effort by the European Commission and European countries to scrutinize potential antitrust behavior ...

Accessed November 25, 2019. 13 Amgen Biosimilars. Amgen And Allergan’s MVASI™ (bevacizumab-awwb) And KANJINTI™ (trastuzumab-anns) Now Available In The United States. July 18, 2019.

and its biosimilar of Roche’s breast cancer drug, Herceptin (trastuzumab). Mundipharma has distribution rights in the UK, Germany, Italy, Ireland, Belgium, Luxembourg and the Netherlands.

The FDA granted orphan drug designation to HLX22 for gastric cancer, advancing global phase 3 trials to improve first-line ...

While the pembrolizumab copy was eye-catching, the firm’s next big biosimilar launch in Europe is a version of Roche’s Herceptin (trastuzumab). Biosimilar companies are poised to launch ...

Number of Medicare claims for trastuzumab originator (Herceptin) and 5 biosimilars, by month, 2019–20 Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases ...

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The "Adalimumab, Infliximab, Etanercept and Trastuzumab Biosimilars market Opportunities and Strategies to 2033" report ...

Forty-one of those biosimilars have launched in the U.S ... Humira® (adalimumab), and Hercessi™, referencing Herceptin® (trastuzumab) — were latecomers entering crowded “first wave ...

The company has eight approved biosimilars referencing drugs including Humira, Immunex’s Enbrel (etanercept) and Genentech’s Herceptin (trastuzumab), amongst others. Samsung Bioepis product ...

Dublin, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The "Adalimumab, Infliximab, Etanercept and Trastuzumab Biosimilars Market Opportunities and Strategies to 2033" report has been added to ...